Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filingsEarnings calendarWatchlist
MORE TOOLS
Gold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

CongressSearchHomeWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View ICUI insider activity ↗

ICUIICU MEDICAL INC/DE

THE LATEST REPORTED YEAR

The company reported a profit.

$732K net income for the year ended December 31, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$2.23BYear ended December 31, 2025
Profit or loss$732KYear ended December 31, 2025
Cash from the business$179.85MYear ended December 31, 2025
Total assets$3.97BAs of June 30, 2026
Total liabilitiesUnavailableNo supported USD fact
Cash & equivalents$208.78MAs of December 31, 2022
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$1.4B
2018-12
$1.27B
2019-12
$1.27B
2020-12
$1.32B
2021-12
$2.28B
2022-12
$2.26B
2023-12
$2.38B
2024-12
$2.23B
2025-12

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
January 1, 2025 – December 31, 2025$2,231,262,000February 19, 202610-K ↗
January 1, 2024 – December 31, 2024$2,382,046,000February 19, 202610-K ↗
January 1, 2023 – December 31, 2023$2,259,126,000February 19, 202610-K ↗
January 1, 2022 – December 31, 2022$2,279,997,000February 27, 202510-K ↗
January 1, 2021 – December 31, 2021$1,316,308,000February 27, 202410-K ↗
January 1, 2020 – December 31, 2020$1,271,004,000February 27, 202310-K ↗
January 1, 2019 – December 31, 2019$1,266,208,000February 25, 202210-K ↗
January 1, 2018 – December 31, 2018$1,400,040,000February 26, 202110-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:Revenues · Retrieved October 15, 2026

Response SHA-256: a6f2ca2661e1877968f211fa3ef6d6d5afc7e113c6a28a09e74d7c55271e5402

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.